Commercial readiness in light of In Vitro Diagnostic Regulation (IVDR)
Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations
Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
The monthly safety report will be made public on the European Medicines Agency website
The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab
Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing
Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others
The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries
Watch this on-demand webinar to learn more about developing analytical methods in regulated environments to detect unexpected impurities
Working with the UK government, first vaccinations are to begin early in the new year
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein